US HB238 | 2025-2026 | 119th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 7 2025 - 25% progression
Action: 2025-01-07 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Status: Introduced on January 7 2025 - 25% progression
Action: 2025-01-07 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Summary
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.
Title
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.
Sponsors
| Rep. David Schweikert [R-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2025-01-07 | House | Referred to the House Committee on Energy and Commerce. |
| 2025-01-07 | House | Introduced in House |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/house-bill/238/all-info |
